Hepatitis C News and Research

RSS
Hepatitis C is a blood-borne virus that infects the liver, where it causes significant inflammation, damage and disruption of normal liver function. According to estimates by the World Health Organization, around 3 to 4 million people worldwide are infected with hepatitis C every year.

The hepatitis C virus is usually transmitted through contact with the blood of an infected individual and, most commonly, people catch it through sharing contaminated needles when injecting illegal drugs.

Hepatitis C infection is categorized into an acute and a chronic stage. The acute phase describes the first 6 months of infection when there are not necessarily any symptoms. Around one quarter of people manage to clear the infection during this stage before disease progresses to the chronic stage.

People who go on to develop chronic hepatitis C may develop jaundice which turns the skin and whites of the eyes yellow. This is caused by the build-up of a yellow-colored substance in the blood called bilirubin that would usually be broken down by the liver if it was healthy. Chronic infection may eventually cause fibrosis and scarring (cirrhosis) of the liver, liver cancer or end stage liver failure.

Hepatitis C can be treated with antiviral medications that that are designed to disrupt the multiplication of virus particles inside the body and prevent liver damage.
Routinely used hospital tool can predict poor outcomes in liver transplant recipients

Routinely used hospital tool can predict poor outcomes in liver transplant recipients

FDA approves new treatment for all HCV genotypes 1-6

FDA approves new treatment for all HCV genotypes 1-6

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

AbbVie hosts roundtable meeting to agree priority actions needed to eliminate hepatitis C in London

AbbVie hosts roundtable meeting to agree priority actions needed to eliminate hepatitis C in London

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

World Hepatitis Day – gearing towards eliminating viral hepatitis by 2030

World Hepatitis Day – gearing towards eliminating viral hepatitis by 2030

ECDC highlights need to scale-up efforts for eliminating viral hepatitis in Europe

ECDC highlights need to scale-up efforts for eliminating viral hepatitis in Europe

New report identifies lack of knowledge about heart disease in prison populations

New report identifies lack of knowledge about heart disease in prison populations

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

Contaminated blood scandal that infected thousands in 70’s and 80’s being investigated

Contaminated blood scandal that infected thousands in 70’s and 80’s being investigated

Preserved placenta is associated with risk of infection

Preserved placenta is associated with risk of infection

Health care battle on hill has veterans defending Obamacare benefits

Health care battle on hill has veterans defending Obamacare benefits

Simple treatment leads to sustained virological response in patients with thalassaemia and HCV

Simple treatment leads to sustained virological response in patients with thalassaemia and HCV

Vaccines can be blamed for any illness even with lack of evidence says EU court

Vaccines can be blamed for any illness even with lack of evidence says EU court

A ‘safe’ space to shoot up: Worth a try in California?

A ‘safe’ space to shoot up: Worth a try in California?

Exclusive: White House task force echoes pharma proposals

Exclusive: White House task force echoes pharma proposals

People in recovery worry GOP Medicaid cuts would put treatment out of reach

People in recovery worry GOP Medicaid cuts would put treatment out of reach

Survey finds parents to be least knowledgeable about invasive pneumococcal disease

Survey finds parents to be least knowledgeable about invasive pneumococcal disease

Opana ER – a long acting opioid painkiller, to be pulled from the markets as per FDA directive

Opana ER – a long acting opioid painkiller, to be pulled from the markets as per FDA directive

UNC researchers identify how class of antiviral drugs interacts with HCV

UNC researchers identify how class of antiviral drugs interacts with HCV